Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-29 @ 2:05 AM
Study NCT ID:
NCT07192432
Status:
RECRUITING
Last Update Posted:
2025-10-10
First Post:
2025-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gene Therapy for HER-Positive Cancer (SENTRY-HER2)
Sponsor:
Vironexis Biotherapeutics Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VNX-202-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None